OSKIRA-Asia-1
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-jRCT2080221801
- Lead Sponsor
- AstraZeneca
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Active rheumatoid arthritis (RA) diagnosed after the age of 16
- 6 or more swollen joints and 6 or more tender/painful joints from certain joints in the hands, wrists, arms and knees
- At least one of:
-positive result for rheumatoid factor test, either in the past or currently (blood test)
-x-ray showing bone erosion within the last 12 months
-presence of certain antibodies in the blood (blood test)
- Currently taking methotrexate for at least 6 months (and on a stable dose for at least 6 weeks)
- Females who are pregnant or breast feeding
- Certain inflammatory conditions (other than rheumatoid arthritis), connective tissue diseases or chronic pain disorders.
- Previously taken, but not responded to, certain biological treatments for rheumatoid arthritis
- High blood pressure that is not controlled by medication
- Low levels of neutrophils in the blood (blood test).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method